HOME >> MEDICINE >> NEWS
Metrifonate, A New Alzheimer Drug, Helps Behavior Problems

St. Louis, May 13, 1998 -- A new drug for Alzheimer patients appears to control psychiatric and behavioral disturbances as well as mental performance. People who took metrifonate were less likely to have hallucinations or be apathetic, depressed and agitated than people who took an inactive substance. Metrifonate also slowed the mental decline associated with Alzheimer's disease over the six-month study. The drug is under review by the Food and Drug Administration as a treatment for patients in the mild to moderate stages of the condition.

"There have been anecdotal reports that patients who take drugs in this class seem brighter, demonstrate more initiative and are easier to get along with in general," says John C. Morris, M.D., the Harvey A. and Dorismae Hacker Friedman Professor of Neurology at Washington University School of Medicine in St. Louis. "This is the first controlled study to document benefits for behavior as well as for memory and thinking, however."

Morris, who co-directs the medical school's Alzheimer's Disease Research Center, participated in the study. He is lead author of a paper in the May issue of the journal Neurology that presents the results. Bayer Corp. funded the clinical research at 24 sites in the United States, including Washington University School of Medicine. Morris reviewed the resulting data as an independent scientist, without compensation from Bayer.

Metrifonate belongs to a class of drugs called acetylcholinesterase (AChE) inhibitors. These drugs slow the breakdown of a chemical messenger called acetylcholine, which is in short supply in the Alzheimer brain. Two AChE inhibitors already are on the market for treatment of Alzheimer's: tacrine (Cognex) and donepezil (Aricept).

The 24 sites in the metrifonate study enrolled 408 mild-to-moderately demented patients. At this stage of the disorder, people usually are capable of dressing, grooming and feeding themselves but are unable to ac
'"/>

Contact: Linda Sage
sage@medicine.WUSTL.edu
314-286-0119
Washington University School of Medicine
20-May-1998


Page: 1 2 3

Related medicine news :

1. Chemical decoy shows promise for slowing Alzheimers by acting as decoy
2. Neuronal death and processing of Tau protein in Alzheimers disease
3. Researchers discover link between insulin and Alzheimers
4. New trials for counseling caregivers and patients with Alzheimers begin
5. Marijuana ingredient may stall decline from Alzheimers
6. Drugs used to treat Alzheimers in nursing homes are worsening sufferers illness
7. UT Southwestern doctors track Oklahoma Alzheimers patients via telemedicine
8. Contrary to previous findings, smoking is detrimental to patients with Alzheimers
9. Nanoscale diagnostic sets sights on Alzheimers
10. New test is first step in early detection of Alzheimers disease
11. Older people with the Alzheimers gene find it harder to remember to remember even if healthy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2019)... , ... August 16, 2019 , ... ... and standardize pharmaceutical and non-pharmaceutical cannabidiol (CBD) products across the CBD market in ... to launch its crowdfunding campaign to raise $50 million on September 9, 2019. ...
(Date:8/16/2019)... PARK, N.Y. (PRWEB) , ... August 16, 2019 ... ... fabricated, and donated a custom handcrafted, one-of-a-kind children’s aircraft to Ronald McDonald House ... was designed to give children residents undergoing medical treatments and their family members ...
(Date:8/16/2019)... ... August 16, 2019 , ... Dr. Demetri Arnaoutakis, ... esteemed Haute Beauty Network. , The Haute Beauty Network, well known for its ... as a hair restoration expert and our newest addition to the Haute Beauty ...
(Date:8/15/2019)... ... 2019 , ... The ASCP Foundation has launched a campaign ... the closure of Hahnemann University Hospital in Philadelphia, which is affiliated with Drexel ... will be making hardship grants of up to $2,500 per resident available to ...
(Date:8/15/2019)... ... August 15, 2019 , ... Jon O'Brien, ... for family planning clinics to provide written assurance that they will comply with ... to the Global Gag Rule, the new policy restricts providers and clinics that ...
Breaking Medicine News(10 mins):
(Date:8/12/2019)... ... August 12, 2019 , ... Intalere, the healthcare industry leader ... as a finalist in the Innovator of The Year - Health IT category of ... be recognized by the Pittsburgh Technology Center as a healthcare IT innovator in the ...
(Date:8/10/2019)... SAN LUIS OBISPO, Calif. (PRWEB) , ... August 10, 2019 , ... ... parents should worry too much about up to 4 years of age, but past ... Perry Patel has recently released a report to help parents know when to intervene ...
(Date:8/9/2019)... Ariz. (PRWEB) , ... August 09, 2019 , ... ... Dr. Austin Cope earned a bachelor’s degree in biology from Dixie State University in ... Texas Tech University and a doctor of medicine from Texas Tech University Health Sciences ...
Breaking Medicine Technology:
Cached News: